Treatment – Biologics
Written by: Ina Fried and Heather Morse | Last reviewed: December 2020
- Seyed Jafari SM, Hunger RE, Schlapbach C. Hidradenitis suppurativa: current understanding of pathogenic mechanisms and suggestion for treatment algorithm. Front Med (Lausanne). 2020 Mar 4;7:68. doi:10.3389/fmed.2020.00068.
- Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019;81(1):91‐101.
- Biological and biosimilar medicines (biosimilars). National Health System. Available at https://www.nhs.uk/conditions/biological-and-biosimilar-medicines/. Accessed 8/12/2020.
- Luther E. Biological treatments. Topics A-Z. DermNet NZ. Available at https://www.dermnetnz.org/topics/biologics/. Accessed 8/12/2020.
- Constantinou CA, Fragoulis GE, Nikiphorou E. Hidradenitis suppurativa: infection, autoimmunity, or both? Ther Adv Musculoskel Dis. 2019 Dec 30;11:1-14. doi:10.1177/1759720X19895488.
- Kimball AB, Okun MM, Williams DA, et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa, N Engl J Med. 2016 Aug 4;375(5):422-434. doi:10.1056/NEJMoa1504370.
- Mac Mahon J, Kirthi S, Byrne N, et al. An update on health-related quality of life and patient-reported outcomes in hidradenitis suppurativa. Patient Relat Outcome Meas. 2020;11:21-26. doi:10.2147/PROM.S174299.
- Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015 Jan;29(4):619-644. doi:10.1111/jdv.12966.
- Ranaweera A. Anakinra. Topics A-Z. DermNet NZ. 2011. Available at https://www.dermnetnz.org/topics/anakinra. Accessed 8/12/2020.
- Ranaweera A. Ustekinumab. Topics A-Z. DermNet NZ. 2011. Available at https://www.dermnetnz.org/topics/ustekinumab. Accessed 8/12/2020.
- Oakley A. Tumour necrosis factor inhibitors. Topics A-Z. DermNet NZ. Available at https://www.dermnetnz.org/topics/tumour-necrosis-factor-inhibitors/. Accessed 8/12/2020.
- Benjamin O, Bansal P, Goyal A, Lappin SL. Disease modifying anti-rheumatic drugs (DMARD). StatPearls. Available at https://www.ncbi.nlm.nih.gov/books/NBK507863/ Accessed 1/29/20.